MEI Pharma, Inc. (NASDAQ:MEIP) Receives Average Recommendation of “Hold” from Analysts
Shares of MEI Pharma, Inc. (NASDAQ:MEIP – Get Free Report) have been given an average rating of “Hold” by the six research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation […]
More Stories
Intertek Group’s (ITRK) “Sector Perform” Rating Reiterated at Royal Bank Of Canada
Royal Bank Of Canada reiterated their sector perform rating on shares of Intertek Group (LON:ITRK – Free Report) in a...
Amazon.com (NASDAQ:AMZN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Amazon.com (NASDAQ:AMZN) had its price objective boosted by JPMorgan Chase & Co. from $240.00 to $255.00 in a research report...
Vistry Group’s (VTY) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reiterated their buy rating on shares of Vistry Group (LON:VTY – Free Report) in a research report...
Secure Trust Bank’s (STB) “House Stock” Rating Reiterated at Shore Capital
Shore Capital reiterated their house stock rating on shares of Secure Trust Bank (LON:STB – Free Report) in a research...
Autodesk (NASDAQ:ADSK) Given Outperform Rating at Macquarie
Macquarie reiterated their outperform rating on shares of Autodesk (NASDAQ:ADSK – Free Report) in a report issued on Friday,Benzinga reports....
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $404.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price upped by Citigroup from $364.00 to $404.00 in a research...